The ascension of Sildenafil initially fueled significant growth in the pharmaceutical sector, producing a image of substantial returns. However, placing capital in companies heavily reliant on blockbuster drugs like https://regandwrl585636.thechapblog.com/39952151/the-blue-pill-and-the-pharmaceutical-industry-a-hazardous-bet